IP Library Granted Patent US 11,059,982
Granted Patent B2
US 11,059,982 · App. 13/889,902 · Granted Jul 13, 2021

Fluid compositions that can form a coating having antiviral properties

Inventor: Henri Rosset (Le Pin, FR)
Assignee: OBERTHUR FIDUCIAIRE SAS
C09D11/00A01N25/04A61L2/18C09D5/14A61L2/232
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,059,982
App. No.
13/889,902
Granted
Jul 13, 2021
Kind
B2
Abstract

The aim of the present invention is to provide a fluid composition that can form a coating, said composition being characterized in that it contains, at least in a solvent medium, an effective amount of at least one natural virucide selected from among lauric acid, monolaurin, lactoferrin and essential oils having antiviral activity and/or one of the precursors thereof, said composition having a viscosity of 30 mPa·s to 40 Pa·s at room temperature and pressure.

Claims (38)

1. A fluid composition capable of forming a virucidal coating on a support, the fluid composition comprising:

a solvent medium;

a biocide, wherein the biocide is monolaurin or lactoferrin, the biocide is the only biocide present in the fluid composition, the biocide is solubilized in the solvent medium, the biocide is present in the fluid composition in an amount from 0.1% w/w to 3% w/w, the biocide is a virucide, and the amount is sufficient to kill or inhibit one or more viruses on the virucidal coating; and

a binder selected from the group consisting of one or more resins, one or more waxes, one or more gums, and any combination thereof,

wherein the fluid composition has a viscosity from 30 mPa·s to 40 Pa·s, at room temperature and ambient pressure, and the virucidal coating is an ink or a varnish.

2. The fluid composition of claim 1 , wherein the biocide kills or inhibits one or more human pathogenic viruses.

3. The fluid composition of claim 1 , further comprising a humectant.

4. The fluid composition of claim 3 , wherein the humectant is a polyol.

5. The fluid composition of claim 3 , wherein weight ratio of mass of the humectant to mass of the virucide is at least equal to 1.

6. The fluid composition of claim 1 , wherein the virucidal coating is the ink, the ink comprises a pigment, and the binder is selected from the group consisting of a polyethylene wax, an acrylic resin, and any combination thereof.

7. The fluid composition of claim 6 , wherein the ink comprises greater than 0% to 60% w/w of the pigment.

8. The fluid composition of claim 1 , wherein the virucidal coating is the varnish, and the binder is selected from the group consisting of a polyethylene wax, an acrylic resin, and any combination thereof.

9. The fluid composition of claim 8 , wherein the varnish is an overprint varnish, and the binder is a cycloaliphatic epoxy resin.

10. A method of coating a surface of a support with a virucidal coating, the method comprising:

providing a support having a surface to be coated; and

applying a fluid composition comprising:

a solvent medium,

a biocide, wherein the biocide is monolaurin, or lactoferrin, the biocide is the only biocide present in the fluid composition, the biocide is solubilized in the solvent medium, the biocide is present in the fluid composition in an amount from 0.1% w/w to 3% w/w, the biocide is a virucide, and the amount is sufficient to kill or inhibit one or more viruses on the virucidal coating, and

virucide

a binder selected from the group consisting of one or more resins, one or more waxes, one or more gums, and any combination thereof,

wherein the fluid composition has a viscosity from 30 mPa·s to 40 Pa·s, at room temperature and ambient pressure, and the virucidal coating is an ink or a varnish.

11. The method of claim 10 , wherein the fluid composition is applied to the surface of the support by a method selected from the group consisting of offset printing, gravure printing, flexography, flexographic overprinting, intaglio printing, typography, lithography, and any combination thereof.

12. A support having a virucidal coating prepared by a process comprising the steps of:

providing the support having at least one surface to be treated; and

applying a fluid composition comprising:

a solvent medium,

a biocide, wherein the biocide is monolaurin or lactoferrin, the biocide is the only biocide present in the fluid composition, the biocide is solubilized in the solvent medium, the biocide is present in the fluid composition in an amount from 0.1% w/w to 3% w/w, the biocide is a virucide, and the amount is sufficient to kill or inhibit one or more viruses on the virucidal coating, and

a binder selected from the group consisting of one or more resins, one or more waxes, one or more gums, and any combination thereof,

wherein the fluid composition has a viscosity from 30 mPa·s to 40 Pa·s, at room temperature and ambient pressure, and the virucidal coating is an ink or a varnish.

13. The fluid composition of claim 1 , wherein the fluid composition contains from 0.1% to 2% w/w of the virucide.

14. The fluid composition of claim 1 , wherein monolaurin is the biocide.

15. The support of claim 12 , wherein monolaurin is the biocide.

16. The fluid composition of claim 1 , wherein the binder comprises a resin, and the fluid composition contains from 15% to 60% w/w of the resin.

17. The support of claim 12 , wherein the binder comprises a resin, and the fluid composition contains from 15% to 60% w/w of the resin.

18. The fluid composition of claim 1 , wherein the binder comprises a wax, and the fluid composition contains greater than 0% to 20% w/w of the wax.

19. The support of claim 12 , wherein the binder comprises a wax, and the fluid composition contains greater than 0% to 20% w/w of the wax.

20. The fluid composition of claim 1 , wherein the biocide kills or inhibits a poliovirus, an influenza virus, or both.

21. The support of claim 12 , wherein the biocide kills or inhibits a poliovirus, an influenza virus, or both.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2025
From: OBERTHUR FIDUCIAIRE SAS
To: VHP SECURITY PAPER B.V.
Reel/Frame 070270/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2018
From: ARJOWIGGINS SECURITY
To: OBERTHUR FIDUCIAIRE SAS
Reel/Frame 047663/0020 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2018
From: OBERTHUR FIDUCIAIRE SAS
To: OBERTHUR FIDUCIAIRE SAS
Reel/Frame 047663/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2013
From: ROSSET, HENRI
To: ARJOWIGGINS SECURITY
Reel/Frame 030567/0421 →
Priority Claims (1)
FR 1059195 · Nov 8, 2010 · national
Continuity (2)
Continuation PCTIB2011054927 · Nov 4, 2011
Related Publication 20140155482A1 · Jun 5, 2014